Free Trial

Dr. Martens (DOCS) Competitors

Dr. Martens logo
GBX 52 -0.90 (-1.70%)
As of 12:36 PM Eastern

DOCS vs. RMG, TEM, SPT, GEN, WIX, YOU, CNIC, NET, SRAD, and SLP

Should you be buying Dr. Martens stock or one of its competitors? The main competitors of Dr. Martens include Royal Mail (RMG), Templeton Emerging Markets Investment Trust (TEM), Spirent Communications (SPT), Genuit Group (GEN), Wickes Group (WIX), YouGov (YOU), CentralNic Group (CNIC), Netcall (NET), Stelrad Group (SRAD), and Sylvania Platinum (SLP). These companies are all part of the "computer software" industry.

Dr. Martens vs.

Royal Mail (LON:RMG) and Dr. Martens (LON:DOCS) are both small-cap business services companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, earnings, media sentiment, dividends, profitability, risk, institutional ownership and community ranking.

Royal Mail pays an annual dividend of GBX 0.17 per share. Dr. Martens pays an annual dividend of GBX 3 per share and has a dividend yield of 5.8%. Royal Mail pays out 27.4% of its earnings in the form of a dividend. Dr. Martens pays out 42.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

69.5% of Dr. Martens shares are held by institutional investors. 4.4% of Dr. Martens shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Royal Mail received 513 more outperform votes than Dr. Martens when rated by MarketBeat users. However, 91.67% of users gave Dr. Martens an outperform vote while only 54.30% of users gave Royal Mail an outperform vote.

CompanyUnderperformOutperform
Royal MailOutperform Votes
524
54.30%
Underperform Votes
441
45.70%
Dr. MartensOutperform Votes
11
91.67%
Underperform Votes
1
8.33%

In the previous week, Dr. Martens had 4 more articles in the media than Royal Mail. MarketBeat recorded 4 mentions for Dr. Martens and 0 mentions for Royal Mail. Dr. Martens' average media sentiment score of 1.35 beat Royal Mail's score of 0.00 indicating that Dr. Martens is being referred to more favorably in the news media.

Company Overall Sentiment
Royal Mail Neutral
Dr. Martens Positive

Dr. Martens has a net margin of 7.89% compared to Royal Mail's net margin of 0.00%. Dr. Martens' return on equity of 18.91% beat Royal Mail's return on equity.

Company Net Margins Return on Equity Return on Assets
Royal MailN/A N/A N/A
Dr. Martens 7.89%18.91%8.12%

Dr. Martens has lower revenue, but higher earnings than Royal Mail. Royal Mail is trading at a lower price-to-earnings ratio than Dr. Martens, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Royal Mail£12.71B0.00N/A£0.61N/A
Dr. Martens£874.20M0.58£68.97M£7.057.37

Summary

Dr. Martens beats Royal Mail on 10 of the 14 factors compared between the two stocks.

Remove Ads
Get Dr. Martens News Delivered to You Automatically

Sign up to receive the latest news and ratings for DOCS and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

DOCS vs. The Competition

MetricDr. MartensFootwear & Accessories IndustryCyclical SectorLON Exchange
Market Cap£504.80M£11.05B£3.18B£2.60B
Dividend Yield1.36%1.71%3.53%4.82%
P/E Ratio7.3719.0820.28141.21
Price / Sales0.5823.3059.73281,678.09
Price / Cash14.2920.2830.5527.94
Price / Book1.383.643.144.61
Net Income£68.97M£168.67M£258.15M£5.78B
7 Day Performance-2.16%-1.00%0.00%1.37%
1 Month Performance-20.79%-9.04%15.44%7.22%
1 Year Performance-40.74%-6.97%1,599.34%108.14%

Dr. Martens Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
DOCS
Dr. Martens
N/AGBX 52
-1.7%
N/A-40.4%£504.80M£874.20M7.37890Dividend Cut
Insider Trade
Gap Up
RMG
Royal Mail
N/AN/AN/AN/A£1.98B£12.71B339.34100
TEM
Templeton Emerging Markets Investment Trust
N/AGBX 174.60
-0.2%
N/A+13.3%£1.82B£160.96M14.00N/APositive News
High Trading Volume
SPT
Spirent Communications
2.0756 of 5 stars
GBX 189.10
-0.2%
GBX 236
+24.8%
+5.1%£1.36B£561.21M102.221,526Positive News
High Trading Volume
GEN
Genuit Group
1.402 of 5 stars
GBX 372.50
-0.5%
GBX 545
+46.3%
-15.8%£923.91M£553.28M39.082,700High Trading Volume
WIX
Wickes Group
2.0779 of 5 stars
GBX 175.60
+1.7%
GBX 189
+7.6%
+16.3%£415.77M£1.45B14.205,930High Trading Volume
YOU
YouGov
2.7966 of 5 stars
GBX 306
-1.0%
GBX 880
+187.6%
-70.7%£358.06M£335.28M-155.951,820News Coverage
High Trading Volume
CNIC
CentralNic Group
N/AN/AN/AN/A£339.82M£790.04M-12,660.00100
NET
Netcall
2.2813 of 5 stars
GBX 115.10
-1.6%
GBX 130
+12.9%
+24.3%£190.26M£39.16M32.413,220
SRAD
Stelrad Group
N/AGBX 136
+2.3%
N/A+11.7%£180.68M£306.97M11.692,960Positive News
SLP
Sylvania Platinum
N/AGBX 53.77
-0.4%
N/A-5.7%£173.52M£99.97M25.20160
Remove Ads

Related Companies and Tools


This page (LON:DOCS) was last updated on 3/28/2025 by MarketBeat.com Staff
From Our Partners